NextCure, Inc. (NXTC) Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Serous Carcinoma - Slideshow (NASDAQ:NXTC) 2026-06-02 | WOBR AI
2026-06-02. The following slide deck was published by NextCure, Inc.
Read on WOBR AI →